Cutaneous mucormycosis by Rhizopus arrhizus treated with isavuconazole as first line therapy: A case report

We report the case of 67-year-old man with idiopathic granulocytic aplasia and a cutaneous lesion caused by Rhizopus arrhizus treated with isavuconazole. Its safety profile and spectrum of activity make it an important therapeutic option.

Source: Medical Mycology Case Reports - October 4, 2019 Category: Biology Source Type: research